Get Practical

on Pathways

Value-based care is here. The question now is, how is your organization utilizing pathways to their fullest in order to realize the most benefit? Enter the Clinical Pathways Congress. Year 3 of the Congress gets very practical—it has been designed to dive in and address the operational questions raised by cancer center directors, clinical pathways directors, medical and pharmacy benefit managers, pathway vendors, and other stakeholders involved on pathway committees—about design, development, implementation, utilization, and outcome measurement.

How do we best analyze our patient data?
How do we incentivize care coordination and pathways adherence?
How does our pathways platform compare to others?
How do we build, improve, or expand our pathways program?
How do we measure outcomes?

The meeting where the pathways conversation turns to action.

2017 PHOTO GALLERY

ASCO® and American Society of Clinical Oncology® are registered trademarks of the American Society of Clinical Oncology, Inc. Used with permission. This is not an ASCO sponsored event.

This program is focused on the critical questions surrounding clinical pathways and the opportunities to develop new strategies that address evidence-based care through:

Design

AND TESTING

Implementation

AND EVALUATION

Impact

ON QUALITY OF CARE, COSTS, AND HEALTH OUTCOMES

2017 Participating Organizations Included:

Cleveland Clinic
Harvard Medical School
Cancer Treatment Centers of America
Lilly
Express Scripts
Dana Farber Cancer Institute
Pfizer Oncology
Moffitt Cancer Center
Flatiron Health
Eisai
McKesson Specialty Health
Roswell Park Cancer Institute
Thomas Jefferson University Hospital
Janssen Biotech
Knight Cancer Institute
Stanford University Medical Center
Genentech
AmerisourceBergen
Maryland Oncology Hematology
NYU Langone Medical Center
Seattle Cancer Care Alliance
Evicore Healthcare

Highlights

Shape

your knowledge of clinical pathways–the program features sessions addressing pathway design, testing, implementation, standards, measurement, and evaluation.

ideas, concerns, challenges, discoveries, and success stories with a community of multidisciplinary stakeholders.

Shed

misconceptions you may have about pathways by connecting with leading faculty with expertise of how to ensure pathways are safe, effective, and evidence-based.

AGENDA